Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.580
-0.046 (-7.30%)
At close: Dec 20, 2024, 4:00 PM
0.596
+0.016 (2.67%)
After-hours: Dec 20, 2024, 7:20 PM EST
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $34.29 million as of December 20, 2024. Its market cap has increased by 40.84% in one year.
Market Cap
34.29M
Enterprise Value
-37.76M
1-Year Change
40.84%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $34.29M, a decrease of -90.61%. That is a compound annual growth rate of -49.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 34.29M | 50.54% |
| Dec 29, 2023 | 22.78M | 2.97% |
| Dec 30, 2022 | 22.12M | -84.16% |
| Dec 31, 2021 | 139.65M | -61.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xilio Therapeutics | 38.09M |
| Nexalin Technology | 37.94M |
| Passage Bio | 37.77M |
| BioVie | 37.61M |
| OncoCyte | 37.04M |
| CalciMedica | 36.94M |
| Enzo Biochem | 36.84M |
| Lexaria Bioscience | 36.82M |